Literature DB >> 21643020

A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT.

M Tanaka, T Tachibana, A Numata, H Takasaki, K Matsumoto, A Maruta, Y Ishigatsubo, H Kanamori.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21643020     DOI： 10.1038/bmt.2011.122

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.

Authors:  M Tanaka; H Kanamori; K Matsumoto; T Tachibana; A Numata; K Ohashi; T Kobayashi; C Nakaseko; Y Kanda; E Yamazaki; S Fujisawa; J Ooi; T Sakura; N Aotsuka; M Onoda; S Machida; J Kato; K Usuki; R Watanabe; J Taguchi; S Yano; T Saito; S Takahashi; H Sakamaki; S Okamoto
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

2.  Prognostic impact of pretransplantation hyperferritinemia in adults undergoing allogeneic hematopoietic SCT: a meta-analysis.

Authors:  Z Wang; M Jia; H Zhao; Y Cheng; Z Luo; Y Chen; X Xu; Y Tang
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.